Letter: low rates of HBV serology testing in patients with chronic hepatitis C receiving direct acting antivirals - Authors' reply.

about

Letter: low rates of HBV serology testing in patients with chronic hepatitis C receiving direct acting antivirals - Authors' reply.

Item

http://www.wikidata.org/entity/Q47615517

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Letter: low rates of HBV serol ...... g antivirals - Authors' reply.

@en

Letter: low rates of HBV serol ...... g antivirals - Authors' reply.

@nl

type

Item

label

Letter: low rates of HBV serol ...... g antivirals - Authors' reply.

@en

Letter: low rates of HBV serol ...... g antivirals - Authors' reply.

@nl

prefLabel

Letter: low rates of HBV serol ...... g antivirals - Authors' reply.

@en

Letter: low rates of HBV serol ...... g antivirals - Authors' reply.

@nl

P1476

Letter: low rates of HBV serol ...... ng antivirals - Authors' reply

@en

P2093

M M Mücke

http://www.w3.org/2001/XMLSchema#string

V T Mücke

http://www.w3.org/2001/XMLSchema#string

P2860

No evidence of hepatitis B virus reactivation in patients with resolved infection treated with direct-acting antivirals for hepatitis C in a large real-world cohort.

Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting System.

Evaluation of hepatitis B reactivation among 62,920 veterans treated with oral hepatitis C antivirals.

Frequency of, and factors associated with, hepatitis B virus reactivation in hepatitis C patients treated with all-oral direct-acting antivirals: Analysis of a Japanese prospective cohort.

Hepatitis B reactivation in patients with chronic hepatitis C undergoing anti-viral therapy with an interferon-free regimen.

The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infection.

[Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection].

Reactivation of hepatitis B virus from an isolated anti-HBc positive patient after eradication of hepatitis C virus with direct-acting antiviral agents.

Letter: low rates of HBV serology testing in patients with chronic hepatitis C receiving direct acting antivirals.

P304

909-910

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/APT.14286

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

J Vermehren

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29023880

http://www.w3.org/2001/XMLSchema#string